Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (131-140 of 324) with videos related to

Pageof 33
Sort By:
Antiviral Therapy|March 27, 2009
A phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patientsSarah L Pett, Michael C McCarthy, David A Cooper, et al.
HIV Clinical Trials|February 6, 2010
Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trialDiane Descamps, Corine Chazallon, Clive Loveday, et al.
AIDS Research and Human Retroviruses|May 6, 2017
Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, AustraliaAngie Pinto, Alex Carrera, Hanan Salem, et al.
AIDS Research and Therapy|March 5, 2017
HIV care in Yangon, Myanmar; successes, challenges and implications for policyNe Myo Aung, Josh Hanson, Tint Tint Kyi, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2004
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertensionOlivier Sitbon, Virginie Gressin, Rudolf Speich, et al.
Sexual Health|December 22, 2012
Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with menLeon P Botes, Sarah Pett, Andrew Carr, et al.
Nephrology (Carlton, Vic.)|July 14, 2017
Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational DatabaseJason Cheung, Rainer Puhr, Kathy Petoumenos, et al.
Lancet (London, England)|February 14, 2004
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trialAndrew Carr, Cassy Workman, Dianne Carey, et al.
Sexual Health|May 20, 2011
Participants' perspectives of high resolution anoscopyRichard J Hillman, Sarah Pett, Debbie Marriott, et al.
JAMA|July 4, 2002
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trialAndrew Carr, Cassy Workman, Don E Smith, et al.
Pageof 33

Showing results (131-140 of 324) with videos related to

Sort By:
Pageof 33
Antiviral Therapy|March 27, 2009
A phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patientsSarah L Pett, Michael C McCarthy, David A Cooper, et al.
HIV Clinical Trials|February 6, 2010
Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trialDiane Descamps, Corine Chazallon, Clive Loveday, et al.
AIDS Research and Human Retroviruses|May 6, 2017
Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, AustraliaAngie Pinto, Alex Carrera, Hanan Salem, et al.
AIDS Research and Therapy|March 5, 2017
HIV care in Yangon, Myanmar; successes, challenges and implications for policyNe Myo Aung, Josh Hanson, Tint Tint Kyi, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2004
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertensionOlivier Sitbon, Virginie Gressin, Rudolf Speich, et al.
Sexual Health|December 22, 2012
Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with menLeon P Botes, Sarah Pett, Andrew Carr, et al.
Nephrology (Carlton, Vic.)|July 14, 2017
Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational DatabaseJason Cheung, Rainer Puhr, Kathy Petoumenos, et al.
Lancet (London, England)|February 14, 2004
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trialAndrew Carr, Cassy Workman, Dianne Carey, et al.
Sexual Health|May 20, 2011
Participants' perspectives of high resolution anoscopyRichard J Hillman, Sarah Pett, Debbie Marriott, et al.
JAMA|July 4, 2002
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trialAndrew Carr, Cassy Workman, Don E Smith, et al.
Pageof 33